242 related articles for article (PubMed ID: 23682813)
1. Hydrogen sulfide attenuates opioid dependence by suppression of adenylate cyclase/cAMP pathway.
Yang HY; Wu ZY; Wood M; Whiteman M; Bian JS
Antioxid Redox Signal; 2014 Jan; 20(1):31-41. PubMed ID: 23682813
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide inhibits opioid withdrawal-induced pain sensitization in rats by down-regulation of spinal calcitonin gene-related peptide expression in the spine.
Yang HY; Wu ZY; Bian JS
Int J Neuropsychopharmacol; 2014 Sep; 17(9):1387-95. PubMed ID: 24824948
[TBL] [Abstract][Full Text] [Related]
3. Exogenous sodium hydrosulfide can attenuate naloxone-precipitated withdrawal syndromes and affect cAMP signaling pathway in heroin-dependent rat's nucleus accumbens.
Jiang LH; Wang J; Wei XL; Liang QY; Cheng TT
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1974-82. PubMed ID: 23242725
[TBL] [Abstract][Full Text] [Related]
4. Opioid-induced mitogen-activated protein kinase signaling in rat enteric neurons following chronic morphine treatment.
Duraffourd C; Kumala E; Anselmi L; Brecha NC; Sternini C
PLoS One; 2014; 9(10):e110230. PubMed ID: 25302800
[TBL] [Abstract][Full Text] [Related]
5. Ser/ Thr residues at α3/β5 loop of Gαs are important in morphine-induced adenylyl cyclase sensitization but not mitogen-activated protein kinase phosphorylation.
Seyedabadi M; Ostad SN; Albert PR; Dehpour AR; Rahimian R; Ghazi-Khansari M; Ghahremani MH
FEBS J; 2012 Feb; 279(4):650-60. PubMed ID: 22177524
[TBL] [Abstract][Full Text] [Related]
6. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
7. Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.
Levitt ES; Purington LC; Traynor JR
Mol Pharmacol; 2011 Mar; 79(3):461-71. PubMed ID: 21098043
[TBL] [Abstract][Full Text] [Related]
8. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways.
Clark MJ; Harrison C; Zhong H; Neubig RR; Traynor JR
J Biol Chem; 2003 Mar; 278(11):9418-25. PubMed ID: 12524446
[TBL] [Abstract][Full Text] [Related]
9. Regulation of adenylyl cyclase, ERK1/2, and CREB by Gz following acute and chronic activation of the delta-opioid receptor.
Tso PH; Yung LY; Wong YH
J Neurochem; 2000 Apr; 74(4):1685-93. PubMed ID: 10737627
[TBL] [Abstract][Full Text] [Related]
10. Modulation of miR-139-5p on chronic morphine-induced, naloxone-precipitated cAMP overshoot in vitro.
Cao DN; Shi JJ; Wu N; Li J
Metab Brain Dis; 2018 Oct; 33(5):1501-1508. PubMed ID: 29916183
[TBL] [Abstract][Full Text] [Related]
11. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
Carter BD; Medzihradsky F
Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
[TBL] [Abstract][Full Text] [Related]
12. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide inhibits A2A adenosine receptor agonist induced β-amyloid production in SH-SY5Y neuroblastoma cells via a cAMP dependent pathway.
Nagpure BV; Bian JS
PLoS One; 2014; 9(2):e88508. PubMed ID: 24523906
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells.
Yu VC; Eiger S; Duan DS; Lameh J; Sadée W
J Neurochem; 1990 Oct; 55(4):1390-6. PubMed ID: 1697894
[TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
16. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
17. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment.
Avidor-Reiss T; Bayewitch M; Levy R; Matus-Leibovitch N; Nevo I; Vogel Z
J Biol Chem; 1995 Dec; 270(50):29732-8. PubMed ID: 8530363
[TBL] [Abstract][Full Text] [Related]
18. Role of extracellular signal-regulated kinases in opioid-induced adenylyl cyclase superactivation in human embryonic kidney 293 cells.
Tso PH; Wong YH
Neurosci Lett; 2001 Dec; 316(1):13-6. PubMed ID: 11720767
[TBL] [Abstract][Full Text] [Related]
19. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.
Nowoczyn M; Marie N; Coulbault L; Hervault M; Davis A; Hanouz JL; Allouche S
Neuropharmacology; 2013 Oct; 73():368-79. PubMed ID: 23792280
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum.
Chartoff EH; Papadopoulou M; Konradi C; Carlezon WA
J Neurochem; 2003 Oct; 87(1):107-18. PubMed ID: 12969258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
